Exact Sciences (Marlborough, Massachusetts) said the company has received a determination from the Nasdaq Stock Market indicating that the company has evidenced compliance with the market capitalization requirements for continued listing on the Nasdaq Capital Market. As a result, the company's securities will continue to trade on that market.

Exact Sciences is a molecular diagnostics company focused on colorectal cancer.

No Comments